학술논문
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): An open-label, randomised, phase 3 trial
Document Type
Article
Author
Middleton, G.; Silcocks, P.; Cox, T.; Greenhalf, W.; Shaw, V.; Costello, E.; Naisbitt, D.; Rawcliffe, C.; Nanson, G.; Neoptolemos, J.; Valle, J.; Wadsley, J.; Propper, D.; Coxon, F.; Ross, P.; Madhusudan, S.; Roques, T.; Cunningham, D.; Falk, S.; Wadd, N.; Harrison, M.; Corrie, P.; Iveson, T.; Robinson, A.; McAdam, K.; Eatock, M.; Evans, J.; Archer, C.; Hickish, T.; Garcia-Alonso, A.; Nicolson, M.; Steward, W.; Anthoney, A.
Source
In: The Lancet Oncology . (The Lancet Oncology, July 2014, 15(8):829-840)
Subject
Language
English
ISSN
14745488
14702045
14702045